To evaluate the efficacy of Swayambhuv Guggulu in Sandhigata Vata

Randomized controlled study of Swayambhuv Guggulu in the management of Sandhigata vata.

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024028

Enrollment

Registered

2020-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M255- Pain in joint

Interventions

Intervention1: Swayambhuv Guggulu: Swayambhuv Guggulu 500 mg 2 BID with mandoshna jala for 28 days Control Intervention1: Trayodashang Guggulu: Trayodashang Guggulu 500 mg 2 BID with mandoshna jala fo

Eligibility

Inclusion criteria

Inclusion criteria: The patients suffering from Sandhigata vata lakshanas. i.e. vatapurna dhruti sparsha, shool, shotha, sandhishaithalya, atopa.

Exclusion criteria

Exclusion criteria: known case of rheumatic arthritis, gout arthritis, pregnant women, lactating mothers, patients suffering from complication like IHD, AR, pulmonary effusion, known case of DM, pulmonary TB, chronic alcoholic, Hypertension.

Design outcomes

Primary

Measure	Time frame
To study the effect of Swayambhuv Guggulu in the management of Sandhigata vata.Timepoint: 4 weeks	—

Secondary

Measure	Time frame
To study the etiopathology of Sandhigata vata.Timepoint: 4 weeks	—

Countries

India

Contacts

Public ContactCHETAN MADHUKAR PARAB

Hon shree Annasaheb Dange Ayurved Medical College Ashta Tal Walawa Dist- Sangli Maharashtra

pdeshmukhe@yahoo.co.in7719954457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026